Menopause and the Climacteric

Menopause is the permanent cessation of menstruation resulting from the loss of ovarian follicular activity, recognized retrospectively after twelve consecutive months without a period. The climacteric is the broader transition surrounding it, encompassing the perimenopausal years of fluctuating ovarian function and the early postmenopause, during which falling estrogen produces the characteristic vasomotor, genitourinary, and other symptoms.

Definition

Menopause is the permanent end of menstruation caused by depletion of ovarian follicular activity, diagnosed retrospectively after 12 consecutive months of amenorrhea; the climacteric is the transitional period of declining and fluctuating ovarian function that surrounds it.

Scope

This entry covers the definition and staging of the menopausal transition, the underlying ovarian and hormonal changes, the principal symptoms and longer-term health correlates, and the way evidence on this life stage is framed. It is reference-educational and does not recommend or dose any therapy.

Key concepts

• Ovarian follicular depletion
• Perimenopause and the menopausal transition
• Vasomotor symptoms (hot flushes, night sweats)
• Genitourinary syndrome of menopause
• Rising FSH and falling estradiol
• Bone loss and cardiovascular change after menopause
• STRAW staging of reproductive ageing

Mechanisms

Menopause results from the progressive exhaustion of the ovarian follicle pool. As follicles diminish, the ovary produces less estradiol and inhibin, removing negative feedback on the pituitary so that follicle-stimulating hormone rises; ovulation becomes irregular and then ceases. The fall in estrogen drives the climacteric symptoms: thermoregulatory instability manifests as hot flushes and night sweats, and estrogen deficiency in urogenital tissues produces the genitourinary syndrome of menopause. Over the longer term, loss of estrogen accelerates bone resorption and is associated with changes in the cardiovascular and metabolic profile. The staging of these changes, from late reproductive years through perimenopause to postmenopause, provides a common framework for describing the transition.

Clinical relevance

The menopausal transition is a universal life stage rather than a disease, and its symptoms range widely in severity. This entry describes the physiology and symptom patterns for reference; decisions about whether and how to treat symptoms, including any use of hormone therapy, are individualized and governed by current guidelines, and no dosing or treatment advice is given here.

Epidemiology

Menopause occurs in all women who reach mid-life, with the natural average age around the early fifties in most populations and earlier onset when it follows surgery or certain medical treatments. Vasomotor symptoms affect a large majority of women during the transition and can persist for years, while genitourinary symptoms tend to be progressive after menopause.

Evidence & guidelines

Menopause societies and endocrine bodies, including the North American Menopause Society and the Endocrine Society, issue position statements on the menopausal transition and its management. These emphasize individualized, symptom-directed care and a benefit-risk assessment for any hormone therapy; they are cited here to characterize the evidence base, not as treatment instructions.

Debates

How should the benefits and risks of menopausal hormone therapy be weighed?

After large trials raised concerns about hormone therapy, professional statements converged on an individualized, timing-dependent framework in which benefits and risks differ by age and time since menopause; the balance for symptom relief versus long-term risk remains an active area of guidance.

Seminal works

• davis-2015
• nams-2017

Frequently asked questions

When is menopause considered to have occurred?

It is diagnosed retrospectively after twelve consecutive months without menstruation, in the absence of another cause, reflecting permanent loss of ovarian follicular activity.

What is the difference between menopause and the climacteric?

Menopause is the single point of the final menstrual period; the climacteric (including perimenopause) is the broader transition of fluctuating and then declining ovarian function around it.